Donate
Sign-in Local Events
Professionals



  1. FDA allows marketing of first A1c test labeled for the diagnosis of diabetes by health care professionals
Cardiac Disease Evaluation and Management Among Kidney and Liver Transplantation
  • Updated:Feb 20,2013
AHA_MPT_CVDaily Banner PON_ScienceNews_DiscussThis



Cardiac Disease Evaluation and Management Among Kidney and Liver Transplantation Candidates

Circ Journal Cover for Science News
  • Cardiovascular disease is a major cause of morbidity and mortality for those with end-stage non-cardiac organ failure both before and after transplantation.
  • The unique characteristics of end-organ failure transplant candidates require careful consideration during cardiac evaluation.
  • This paper addresses gaps in existing guidelines for consideration during cardiac disease evaluation in kidney and liver transplant candidates.
 
Read the full article in Circulation
Circulation. 2012: published online before print July 2, 2012, 10.1161/CIR.0b013e31823eb07a.

Supporting Materials
  • Commentary:  Bringing Harmony to the Cacophony of Cardiovascular Disease Assessment for Potential Kidney Liver Transplant Candidates. A Case for Assimilating the New AHA/ACCF Guidelines by Christopher deFilippi, MD
  • Top 10 Things To Know
 Other Resources
Related Statements and Guidelines
Did you see these recent Commentaries?
Commentaries View All

Connect with AHA Science News
twitter_FollowAHAScience
fb_LikeAHAScienceNews
Network with over 30,000 Heart
and Stroke Professionals
DS-5610 PON Banner 280X137
  • Gain access to career-enhancing information
  • Connect with others around the world
  • Share and discuss articles by prominent heart and stroke researchers
     
    Join the AHA's Professional Online Network at networking.americanheart.org    Login to AHA's Professional Online Network at networking.americanheart.org
Science News View All